The Effect of Laryngeal Manual Therapy as a Management of Globus
1 other identifier
interventional
70
1 country
1
Brief Summary
The purpose of this study is to assess the effect of laryngeal manual therapies in the treatment of globus (sensation of a lump in the throat).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 16, 2020
CompletedFirst Posted
Study publicly available on registry
June 17, 2020
CompletedStudy Start
First participant enrolled
March 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2023
CompletedAugust 3, 2022
August 1, 2022
1.3 years
June 16, 2020
August 2, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Change From symptomatic to asymptomatic patient
after one therapy session we will evaluate the effect of the therapy on the patients .
baseline and week 1
Study Arms (1)
laryngeal manual therapies
OTHERThe laryngeal manual therapy incorporates massaging the laryngeal muscles thus reducing excessive tension in the laryngeal and perilaryngeal musculature in patients with globus .
Interventions
The laryngeal manual therapy incorporates massaging the laryngeal muscles thus reducing excessive tension in the laryngeal and perilaryngeal musculature in patients with globus .
Eligibility Criteria
You may qualify if:
- patients more than 18 years old
- male and females
- patients complaning from Globus without an organic cause
- patients who underwent throat endoscopy and was normal.
- Patients who received conventional drug therapy without benefit.
- Globus complaints more than two months .
You may not qualify if:
- below 18
- Patients diagnosed with reflux(as a cause to globus)
- Patients who considered at high risk of reflux according to REFLUX SYMPTOM INDEX (RSI) more than 13
- patients who diagnosed with reflux and improved after anti-reflux manegment .
- patients with laryngeal disease/finding that can explain the globus.
- patients with organic cause that can explain the globus .
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Haemek Medical Center
Afula, Israel
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Miki Paker, MD
HaEmek Medical Center, Israel
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
June 16, 2020
First Posted
June 17, 2020
Study Start
March 1, 2022
Primary Completion
June 1, 2023
Study Completion
July 1, 2023
Last Updated
August 3, 2022
Record last verified: 2022-08